Key result
Primary VTE prophylaxis trials show widespread methodological flaws, with only ~21% adhering to ITT analysis.
Why the study?
Trials assessing strategies for venous thrombo-embolism prevention had been subject to methodological criticisms, prompting a systematic evaluation of the methodological issues raised by primary VTE prophylaxis trials.
Systematic Review (n=77)
Randomized controlled trials assessing primary VTE prophylaxis frequently suffer from major methodological flaws including undefined primary endpoints, high rates of missing data (especially with venography), and poor compliance with intention-to-treat analysis.
Answers are grounded in this paper and cite their sources.
VTE prophylaxis RCTs show frequent missing data and ITT violations; challenges confidence in prior findings and extends emphasis on rigorous methods for future trials.
AIMS: Many trials have been conducted to assess the efficacy of various strategies in the prevention of venous thrombo-embolism (VTE). Some of these trials have been subject to methodological criticisms. We aimed to assess the methodological issues raised by VTE trials. METHODS AND RESULTS: We searched MEDLINE and the Cochrane Central Register of Controlled Trials for articles assessing primary thromboprophylaxis published between 1994 and 2003 in 60 general medical and specialty journals. A total of 77 articles were analysed by two independent reviewers using a list of items. No primary endpoint was defined in 20% of trials. Although the primary endpoint was collected before day 15 in 75% of trials, there were >/=20% missing data in 56% of articles and >/=30% in 24.2% of articles. The rate of missing data was 23.7+/-9.7% in studies using venography-detected deep-vein thrombosis as an endpoint compared with 5.6+/-6.0% in studies using other endpoints. Among the 47 superiority trials, 27 (57.4%) reported an intention-to-treat (ITT) analysis, but only 10 (21.3%) reported an analysis that complied with this principle. These results were consistent when limiting the analysis to articles published in high-impact journal (impact factor more than 5). CONCLUSION: Recent randomized controlled trials assessing prophylactic regimens in VTE have important methodological limitations in terms of primary endpoints, missing data, and compliance with the ITT principle. These methodological shortcomings should be addressed when planning future trials.
No takes yet. Share an insight, caveat, or question.
Thabut et al. (2005) conducted a systematic review in Venous thrombo-embolism (VTE) (n=77). Primary VTE thromboprophylaxis trial methodology was evaluated on Methodological issues (undefined primary endpoint, missing data, and intention-to-treat compliance). Trials assessing primary VTE prophylaxis lacked defined primary endpoints in 20%, had >=20% missing data in 56%, and complied with ITT analysis in only 21.3% of superiority trials.
Synapse has enriched 10 related papers. Consider them for comparative context: